Lidocaine hydrochloride 0.04 MG/MG Topical Gel — RxCUI 1010077
RxNorm drug concept · Semantic clinical drug
RxCUI 1010077
Semantic clinical drug · SCD
● Current RxNorm concept 19 FDA products
31 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1010077
Official nameLidocaine hydrochloride 0.04 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslidocaine hydrochloride 4 % Topical Gel; lidocaine HCl 4 % Topical Gel
FDA products mapped19
Package NDCs mapped31
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- This patch is used to treat post-herpetic neuralgia — that's the persistent burning or aching nerve pain that sometimes sticks around after a shingles outbreak, even after the rash...
- What is this patch actually for — why did my doctor prescribe it?
- You wear it for up to 12 hours, then take it off for the next 12 hours — think of it as '12 hours on, 12 hours off.' Your prescriber may allow up to 3 patches at a time, but never...
- How long do I wear the patch, and can I wear more than one?
🕸️ Concept Web — How Lidocaine hydrochloride 0.04 MG/MG Topical Gel Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Lidocaine hydrochloride 0.04 MG/MG Topical Gel
RxCUI 1010077 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Lidocaine
6387IN -
Lidocaine hydrochloride
142440PIN
-
Lidocaine
-
Brand names 3
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Alocane
1487000BN -
Derma Numb
1312261BN -
Tranzarel
1872968BN
-
Alocane
-
Dose forms 15
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lidocaine Topical Gel
377965SCDF -
Lidocaine hydrochloride Topical Gel
2648601SCDFP -
Lidocaine Topical Product
1164666SCDG -
Lidocaine hydrochloride Topical Product
2661923SCDGP -
Lidocaine Topical Gel [Alocane]
1875236SBDF -
Lidocaine Topical Gel [Derma Numb]
1747491SBDF -
Lidocaine Topical Gel [Tranzarel]
1872970SBDF -
Lidocaine hydrochloride Topical Gel [Alocane]
2655674SBDFP - +7 more in this family
-
Lidocaine Topical Gel
-
Clinical & branded drugs 7
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lidocaine hydrochloride 0.04 MG/MG
1010076SCDC -
Lidocaine hydrochloride 0.04 MG/MG Topical Gel [Alocane]
1875237SBD -
Lidocaine hydrochloride 0.04 MG/MG Topical Gel [Derma Numb]
1747492SBD -
Lidocaine hydrochloride 0.04 MG/MG Topical Gel [Tranzarel]
1872972SBD -
Lidocaine hydrochloride 0.04 MG/MG [Alocane]
1875235SBDC -
Lidocaine hydrochloride 0.04 MG/MG [Derma Numb]
1747490SBDC -
Lidocaine hydrochloride 0.04 MG/MG [Tranzarel]
1872969SBDC
-
Lidocaine hydrochloride 0.04 MG/MG
Showing up to 8 concepts per family — 20 of 27 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Lidocaine hydrochloride 0.04 MG/MG
SCDC · 1010076 -
Lidocaine Topical Gel
SCDF · 377965 -
Lidocaine hydrochloride Topical Gel
SCDFP · 2648601 -
Lidocaine Topical Product
SCDG · 1164666 -
Lidocaine hydrochloride Topical Product
SCDGP · 2661923
Brand-Name Concepts
-
Lidocaine hydrochloride 0.04 MG/MG Topical Gel [Alocane]
SBD · 1875237 -
Lidocaine hydrochloride 0.04 MG/MG Topical Gel [Derma Numb]
SBD · 1747492 -
Lidocaine hydrochloride 0.04 MG/MG Topical Gel [Tranzarel]
SBD · 1872972 -
Lidocaine hydrochloride 0.04 MG/MG [Alocane]
SBDC · 1875235 -
Lidocaine hydrochloride 0.04 MG/MG [Derma Numb]
SBDC · 1747490 -
Lidocaine hydrochloride 0.04 MG/MG [Tranzarel]
SBDC · 1872969 -
Lidocaine Topical Gel [Alocane]
SBDF · 1875236 -
Lidocaine Topical Gel [Derma Numb]
SBDF · 1747491 -
Lidocaine Topical Gel [Tranzarel]
SBDF · 1872970 -
Lidocaine hydrochloride Topical Gel [Alocane]
SBDFP · 2655674
📦 FDA Products & Package NDCs
19 products · 31 package NDCs
31 package NDCs map to RxCUI 1010077 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00363-2020-25 | 1 TUBE in 1 CARTON (0363-2020-25) / 74 g in 1 TUBE | WALGREENS BURN | WALGREENS | 2021-07-16 |
| 00363-7801-02 | 71 g in 1 BOTTLE, PLASTIC (0363-7801-02) | Walgreens Cool n Heat Lidocaine | Walgreens Co | 2023-12-27 |
| 42507-0916-01 | 73 g in 1 BOTTLE (42507-916-01) | Roll-On Pain Relief Liquid | HyVee Inc | 2026-03-01 |
| 68229-0201-02 | 1 TUBE in 1 CARTON (68229-201-02) / 110 mL in 1 TUBE (68229... | Alocane Emergency Burn | Quest Products, LLC. | 2019-03-01 |
| 68229-0201-03 | 110 mL in 1 BOTTLE, SPRAY (68229-201-03) | Alocane Emergency Burn | Quest Products, LLC. | 2020-03-01 |
| 68229-0201-05 | 24 PACKET in 1 CARTON (68229-201-05) / 3.4 mL in 1 PACKET (... | Alocane Emergency Burn | Quest Products, LLC. | 2020-03-01 |
| 68229-0201-07 | 45 PACKET in 1 CARTON (68229-201-07) / 3.4 mL in 1 PACKET (... | Alocane Emergency Burn | Quest Products, LLC. | 2020-03-01 |
| 68229-0201-08 | 103.507 mL in 1 BOTTLE, SPRAY (68229-201-08) | Alocane Emergency Burn | Quest Products, LLC. | 2020-03-01 |
| 68229-0201-10 | 1 TUBE in 1 CARTON (68229-201-10) / 118.294 mL in 1 TUBE (6... | Alocane Emergency Burn | Quest Products, LLC. | 2019-03-01 |
| 68229-0201-11 | 133.081 mL in 1 BOTTLE, SPRAY (68229-201-11) | Alocane Emergency Burn | Quest Products, LLC. | 2020-03-01 |
| 68229-0201-13 | 1 BAG in 1 CARTON (68229-201-13) / 800 mL in 1 BAG (68229-2... | Alocane Emergency Burn | Quest Products, LLC. | 2019-03-01 |
| 68229-0201-16 | 124 mL in 1 BOTTLE, SPRAY (68229-201-16) | Alocane Emergency Burn | Quest Products, LLC. | 2022-11-11 |
| 68229-0201-18 | 1 TUBE in 1 CARTON (68229-201-18) / 22 mL in 1 TUBE (68229-... | Alocane Emergency Burn | Quest Products, LLC. | 2021-12-09 |
| 68229-0600-01 | 1 TUBE in 1 CARTON (68229-600-01) / 118.294 mL in 1 TUBE (6... | SunBurnt PLUS | Quest Products, LLC. | 2020-07-01 |
| 68229-0601-02 | 1 TUBE in 1 CARTON (68229-601-02) / 118 mL in 1 TUBE (68229... | SunBurnt PLUS | Quest Products, LLC. | 2024-02-23 |
| 69396-0188-01 | 1 BOTTLE in 1 BOX (69396-188-01) / .073 L in 1 BOTTLE | Pain Relief Gel-Roll On | Trifecta Pharmaceuticals USA | 2026-04-30 |
| 69396-0188-02 | 2 BOTTLE in 1 BOX (69396-188-02) / .073 L in 1 BOTTLE | Pain Relief Gel-Roll On | Trifecta Pharmaceuticals USA | 2026-04-30 |
| 69842-0309-25 | 1 TUBE in 1 CARTON (69842-309-25) / 74 g in 1 TUBE | CVS Maximum Strength Burn | CVS Pharmacy | 2022-01-01 |
| 70188-0005-01 | 28 g in 1 PACKAGE (70188-005-01) | Derma Numb Pain Relief | A.T.S. Laboratories, LLC | 2015-07-01 |
| 70188-0005-04 | 113 g in 1 PACKAGE (70188-005-04) | Derma Numb Pain Relief | A.T.S. Laboratories, LLC | 2015-07-01 |
| 70188-0006-01 | 57 g in 1 PACKAGE (70188-006-01) | DermaNumb Analgesic | A.T.S. Laboratories, LLC | 2015-07-01 |
| 72835-0447-01 | 70 g in 1 BOTTLE, WITH APPLICATOR (72835-447-01) | Lidovyx | V2 Pharma LLC | 2026-06-25 |
| 72839-0087-02 | 1 BOTTLE in 1 CARTON (72839-087-02) / 71 g in 1 BOTTLE | DCH Pain Relief Roll-On | Derma Care Research Labs, LLC | 2022-04-21 |
| 72839-0108-02 | 71 g in 1 JAR (72839-108-02) | Warrior Pain Relief Roll-On Maximum Strength | Derma Care Research Labs, LLC | 2020-08-14 |
| 72839-0185-04 | 118 mL in 1 BOTTLE (72839-185-04) | Warrior Burn Relief Aloe Maximum Strength | Derma Care Research Labs, LLC | 2022-07-25 |
| 73716-0003-05 | 5 mL in 1 POUCH (73716-003-05) | Relief Gel | Good Clean Love, Inc. | 2022-04-08 |
| 73716-0003-29 | 1 TUBE in 1 CARTON (73716-003-29) / 29 mL in 1 TUBE | Relief Gel | Good Clean Love, Inc. | 2022-04-08 |
| 78589-0257-03 | 85 g in 1 BOTTLE (78589-257-03) | Mirakel Pain Relief Roll-On | Sanvio, Inc. | 2023-03-01 |
| 79481-1087-02 | 71 g in 1 BOTTLE (79481-1087-2) | Meijer Pain Relief | Meijer | 2021-08-31 |
| 80551-0001-03 | 113 g in 1 BOTTLE (80551-001-03) | Burn Relief Aloe | Acutens | 2021-03-18 |
| 84615-0007-02 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (84615-007-02) / 59 m... | POMG NIGHT TIME PAIN RELIEF ROLLER | POMG LLC | 2024-12-06 |
Observed labelers:
Quest Products, LLC. (12) ·
A.T.S. Laboratories, LLC (3) ·
Derma Care Research Labs, LLC (3) ·
Good Clean Love, Inc. (2) ·
Trifecta Pharmaceuticals USA (2) ·
Acutens (1)
· +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.